 |
Anna Protopapas
SVP Corporate Development
Millennium |
 |
|
| |
Arne Wörn PhD
Head Alliance Management
Immunology & Infectious Diseases Business Franchise
Global Business Development & Licensing
Novartis Pharma |
 |
|
 |
Bruce Halpryn
Sr. Director, Health Care Business Development, IP & Technical Due Diligence, IP Management
P&G |
 |
|
 |
Catherine Sazdanoff
VP Global Licensing
Takeda |
 |
|
 |
Chris Seaton
Senior Vice President, Global Transactions
Bayer |
 |
|
 |
David Wurtman
Vice President, Business Development
NexBio |
 |
|
| |
David Paterson
VP Business Development
Impax Pharmaceuticals |
 |
|
 |
David Kalergis
CEO
Diffusion Pharmaceuticals |
 |
|
 |
David Thompson
Director of Marketing & Alliance Management
Eli Lilly |
 |
|
 |
Ellen Locker
Senior Director, Alliance Management
Merck |
 |
|
| |
Iain Dukes
President and CEO
Essentialis |
|
|
| |
Ira Weisberg
Vice President, Business Development
Lifecycle Pharma |
|
|
 |
Jamsheed Banaji
Senior Director, Team Leader, International Business Development
Pfizer Inc |
 |
|
 |
Ira Weiss
CFO
BioDTech |
 |
|
 |
Jeffrey Totten
Vice President
Dean & Co |
 |
|
 |
Jessica Hunt
VP Business Development
Gerson Lehrman Group |
 |
|
 |
Jim Hattersley
Vice President, Business Development
Sun Pharmaceuticals |
 |
|
| |
John Engel
Partner
Engel & Novit |
|
|
| |
John Celebi
Vice President, Business Development
ArQule, Inc. |
|
|
| |
Jonathan Montagu
Vice President, Business Development
Concert Pharmaceuticals |
 |
|
 |
Jules Musing
VP Licensing & Business Development
Johnson and Johnson |
 |
|
 |
Kia Motesharei
Vice President, Business Development
Genfit |
 |
|
 |
Laura Berezin
Partner
Cooley Godward Kronish LLP |
|
|
 |
Len Smith
Senior Intellectual Property Counsel
Novo Nordisk |
 |
|
| |
Lesley Stolz
Vice President, Corporate & Business Development
Sunesis Pharmaceuticals, Inc. |
|
|
 |
Mark Miller
Senior Director of Corporate Business Development
Eli Lilly |
|
|
| |
Matt Reber
Vice President, Business Development
Cowen Healthcare Royalty Partners |
|
|
 |
Matt Meyer
Vice President, Business Development
Cerimon |
 |
|
 |
Mike Leonetti
Head, Healthcare Partnerships
Boehringer-Ingelheim |
 |
|
 |
Pavan Handa
Vice President, Business Development
Noven Pharmaceuticals |
 |
|
| |
Reid Leonard
VP Business Development
Merck |
|
|
| |
Sanj Singh
CEO
Ade Therapeutics |
|
|
| |
Stephanie Hsieh
Senior Director, Intellectual Property and Legal Affairs
Impax Laboratories |
|
|
| |
Stephen Potter
Senior Vice President, Corporate and Business Development
Genzyme |
 |
|
 |
Steve Xanthoudakis
Director, Licensing and Business Development
Merck |
|
|
| |
Thanos Maroglou
Vice President, Business Development
Chimerix |
 |
|
 |
Till Mary
Legal Advisor
US Patent and Trademark Office |
|
|
| |
Vidal De La Cruz
Vice President, Business Development
Cytokine PharmaSciences, Inc. |
|
|
 |
Woody Bryan
Vice President, Business Development
Supernus Pharma |
 |
|
| |
Yogish Kamath
Manager of New Business Development
Intellipharmaceutics |
|
